Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches
Mammalian Genome · 2025
DOI: 10.1007/s00335-025-10121-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mammalian Genome, 2025. Verfasst von Sara Marcó und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Animal Biotechnology and Gene Therapy, Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Universitat Autònom…. Hauptthemen laut MEDLINE: Genetic Therapy, Disease Models, Animal, Lysosomal Storage Diseases, Musculoskeletal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, European Union, by Generalitat de Catalunya, CIBER-Consorcio Centro de Investigación Biomédica en Red.
Abstract (Originalsprache)
Mice have been a cornerstone of biomedical research for decades for studying a wide range of biological processes, disease mechanisms, and the assessment of therapies. Moreover, mice present several practical advantages such as small size, low cost and ease of genetic manipulation. While mice offer numerous benefits, for certain disease areas, rat models provide a closer representation of human disease progression, offering better insights for translational research and therapeutic development. This closer resemblance is particularly important for research focusing on diseases involving the cardiovascular and musculoskeletal system. In rats, the pathophysiology of these diseases mirrors the clinical alterations observed in humans. This review focuses on the key phenotypic differences between mouse and rat models of lysosomal storage disorders that specifically manifest with cardiac, skeletal muscle, and bone and joint involvement (Pompe and Danon diseases, and Maroteaux-Lamy and Morquio A syndromes). Furthermore, we discuss the therapeutic potential of various adeno-associated viral vector-mediated gene therapies that have been evaluated in these rat models, highlighting their contributions to advancing treatment options for these debilitating conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Animal Biotechnology and Gene Therapy, Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
- Center of Animal Biotechnology and Gene Therapy, Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. veronica.jimenez@uab.cat.
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- European Union, by Generalitat de Catalunya
- CIBER-Consorcio Centro de Investigación Biomédica en Red
- Universitat Autònoma de Barcelona
Zitieren
APA
Marcó, S., Muñoz, S., Bosch, F., & Jimenez, V. (2025). Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches. Mammalian Genome. https://doi.org/10.1007/s00335-025-10121-3
Vancouver
Marcó S, Muñoz S, Bosch F, Jimenez V. Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches. Mammalian Genome. 2025. doi:10.1007/s00335-025-10121-3
BibTeX
@article{Marc2025,
author = {Marcó, Sara and Muñoz, Sergio and Bosch, Fatima and Jimenez, Veronica},
title = {Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches},
journal = {Mammalian Genome},
year = {2025},
doi = {10.1007/s00335-025-10121-3}
}
EUVIMED